Calidi Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Calidi Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2022 to Q2 2024.
  • Calidi Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.52M, a 23.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.52M -$1.06M -23.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.8M -$1.03M -21.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.07M +$3.87M +1947% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $4.33M +$4.14M +2144% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.58M Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $4.83M Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $199K Dec 31, 2022 10-K 2024-03-15
Q3 2022 $193K Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.